Chromatin modifications at PLZF/RARA target genes. by Salvatore Spicuglia (204765)

Immunohistochemical staining of PTPN12 protein in HCC and noncancerous liver tissues. by Rong-Zhen Luo (131061)

Golgi-160 was essential for agglutination level of the GA and GDNF improved it. by Chuan-Xi Tang (6274154)

“…<p>(A and B) Immunofluorescence and GA agglutination level analysis in the control group, with or without 50 ng/ml GDNF treatment. …”

miR-206 Represses Hypertrophy of Myogenic Cells but Not Muscle Fibers via Inhibition of HDAC4 by Catherine E. Winbanks (254760)

Blockage of cancer-derived IgG by anti-human IgG antibody inhibits biological behaviors of CRC cells. by Na Niu (103896)

Identification of female and male PGC-specific-expressed genes. by Akihiko Sakashita (839552)

Effectiveness of EGP-based intervention. by Jeremy Hadidjojo (212716)

Spillover Effects of Loss of Control on Risky Decision-Making by Birgit M. Beisswingert (2548387)

Specificity of the dJun-FRET biosensor. by Andrea Maria Pereira (192798)

Comparable gene expression changes among short, and long-term curcumin-treated cells. by Alexander Link (144815)

DOC resource use. by Gabriel Singer (200630)

Summary of alpha connectivity changes. by Srivas Chennu (297764)

The specificity and efficiency of TRPC3 and TRPC6 knockdown. by Kexin Meng (564786)

“…<p>(A, B) Real-time PCR experiments showed that the TRPC3 siRNA (A) and TRPC6 siRNA (B) decreased the mRNA expression of TRPC3 and TRPC6, respectively (*p<0.05 vs. …”

Catalytic activity of PhKAT. by Ken Okada (154758)

Harvey Monroe Hall Research Natural Area trail monitoring study: 1993 vegetation and trail conditions by Eric E. Knapp (2795719)

Sample-based PCA and learning performance. by Alessandro Ingrosso (5812862)

“…Outputs are i.i.d Gaussian. Parameters: <i>N</i> = 1000, <i>f</i>_E = 0.8, <i>γ</i> = 0.1, , <i>σ</i>_I = 2<i>σ</i>_E = 0.6. …”

Overexpression or knock down of NeuroD protein in the system. by Yue Zhang (30585)

“…The NeuroD cDNA virus increases the total number of NeuroD expressing cells in the DG by 1.8-fold compared to the no-injection control, while NeuroD siRNA decreases the number of NeuroD expressing cells in the DG to 0.53-fold of the control (N = 4,*p<0.05, **p<0.01). …”

(5Z)-7-Oxozeaenol- and compound C-induced effects on survival and relative numbers of VIP-immunoreactive (IR) neurons. by Ulrikke Voss (492410)

“…<p>A. shows neuronal survival, expressed as % of controls, after exposure to TAK-1 inhibitor (5Z)-7-Oxozeaenol (10⁻⁷–10⁻⁵ M). …”

Changes in the blood gases during extracorporeal perfusion. by Andreas M. Fichter (527494)

MR image before and after shunt surgery. by Koichi Mitsuya (6195227)